| 000 | 01826 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517081131.0 | ||
| 264 | 0 | _c20160719 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a0006-3002 | ||
| 024 | 7 |
_a10.1016/j.bbamcr.2016.02.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZiegler, Verena | |
| 245 | 0 | 0 |
_aLovastatin protects keratinocytes from DNA damage-related pro-apoptotic stress responses stimulated by anticancer therapeutics. _h[electronic resource] |
| 260 |
_bBiochimica et biophysica acta _cJun 2016 |
||
| 300 |
_a1082-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aAtaxia Telangiectasia Mutated Proteins _xmetabolism |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aCheckpoint Kinase 1 |
| 650 | 0 | 4 |
_aDNA Damage _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDose-Response Relationship, Radiation |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aHistones _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aKeratinocytes _xdrug effects |
| 650 | 0 | 4 |
_aLovastatin _xpharmacology |
| 650 | 0 | 4 |
_aProtein Kinases _xmetabolism |
| 650 | 0 | 4 | _aRadiation, Ionizing |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aAlbers, Anne | |
| 700 | 1 | _aFritz, Gerhard | |
| 773 | 0 |
_tBiochimica et biophysica acta _gvol. 1863 _gno. 6 Pt A _gp. 1082-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbamcr.2016.02.009 _zAvailable from publisher's website |
| 999 |
_c25732305 _d25732305 |
||